USA Series DUR-8 Durable Flexible Ureteroscope System

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> PRODUCTS

Products	USA Series DUR-8 Durable Flexible Ureteroscope System
Company	GYRUS ACMI
Item	USA Series DUR-8 Durable Flexible Ureteroscope System
Features	Patented cable compensation system with 1-year cable breakage warranty and 1-year free deflection adjustments > Durable dual deflection Beveled 6.8 Fr tip and durable 8.7 Fr shaft > Insertion with little or no dilation Large 3.6 Fr working channel and lubricious inside surface > Facilitates easy passage of devices Field of view may be cleared with irrigation while using a 3 Fr instrument > Large image size; clear field of view Removable/rotatable light guide, and rotating biopsy and irrigation ports > Built-in convenience
Description	The ACMI USA Series DUR-8 Durable Flexible Ureteroscope permits direct visualization and access to the entire intrarenal collecting system with little or no dilation. A tight bend radius and superior secondary deflection allow complete intrarenal access, including the lower pole calyces. Dual deflection facilitates access to the proximal ureter and the renal pelvis. The 6.75 beveled tip facilitates passage into the ureteral orifice with little or no dilation. The DUR-8s features, such as its lubricious outer covering on the 8.7 Fr shaft, 6.8 Fr beveled tip, 3.6 Fr working channel, patented cable compensation system, patented torque-stable shaft construction, 12 direction of view, dual light transmission, rotating light post and Luer lock irrigation and biopsy ports, and detachable light guide, provide optimal instrument performance to maximize operating convenience. The DUR-8 is also ideal for reaching proximal ureteral and renal stones with a 200 micron laser fiber or small lithotripsy probe. The DUR-8, in combination with the ACMI 1.9 Fr or 3 Fr electrohydraulic lithotripsy probe, is a cost-effective treatment option for treating stone patients.
Info	GYRUS ACMI Customer Service: (508) 804-2600 Web site: http://www.acmicorp.com

TAG: USA Series DUR Durable Flexible Ureteroscope System

...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...

Medicine Products:

Allergen, Food, Cherry Allergen, Food, Chicken Allergen, Food, Casein Allergen, Food, Blueberry

(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...

(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...

(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...

(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...

[0] Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use [0] Medicare Advantage Plans Struggle to Comply With New Federal Law [0] Longs Drug Stores Corporation Reports Second Quarter Results [0] WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History

...ST, the peer-reviewed journal of the American Coll...dietary intake of certain nutrients increases the ... especially in teens who smoke. Teenagers who for...e a harder time catching their breath. Furthermore...

...2007, issue of Neurology, the medical journal of t...ly Parkinsons disease report a higher than anticip...leepiness, and swelling. By identifying risk fact...isions, allow for early intervention and possibly ...

...mpaign to boost fruit and vegetable intake among y... Professor Janet Cade and colleagues of Leeds Un...nd Vegetable Scheme (SFVS), installed in 2004, on ... the north of England. A specially devised measure...

...therapy (HRT) should not be prescribed to older wo...ent chronic conditions such as heart disease . But...hort term treatment for younger women in early men...oms and improve quality of life. In 2002, the Wom...

Other Medicine News:Health News:Apple a Day Keeps Asthma Away 2 Health News:Apple a Day Keeps Asthma Away 3 Health News:Early Parkinsons Show Hallucination,sleepiness 2 Health News:Britains Free Fruit -And -Vegetable -Scheme Falls Flat 2 Health News:Study Confirms No HRT Benefit for Older Women 2 Health News:Study Confirms No HRT Benefit for Older Women 3

Apple a Day Keeps Asthma Away Early Parkinsons Show Hallucination,sleepiness Britains Free Fruit -And -Vegetable -Scheme Falls Flat Study Confirms No HRT Benefit for Older Women

(Date:8/17/2008)...- Pharmaxis,(ASX: PXS; Nasd...hase 3,clinical trial of Bronchitol for the treatm...The first efficacy data from the trial is expected...e trial commenced its dosing phase in,April 2007, ...ects in June,2008 and closed today with 325 subjec...

(Date:8/14/2008)... showing clinical benefit in cancer,patients; Blin... and attack cancer ce.../ -- Micromet, Inc.,(Nasdaq: MITI ), a biopharmac...bodies for the treatment of cancer, inflammation a...n of a Phase 1 clinical study(1) on its,BiTE(R) an...

(Date:8/13/2008)...all/ -- As biotechnology,pharmaceutical and medic...als beyond their own borders to other parts of the...rica, complicated regulatory environments,challeng...o an analysis by,Aon Corporation (NYSE: AOC ). Ao...ompanies a visual representation of the complex in...

(Date:8/13/2008).../ -- Today positron emission,tomography (PET) scan...gy,tool for diagnosis, staging and monitoring. It ...logy emitting a radioactive tracer to localize,tum...normal tissue. As a,result, the malignant tissue s... spot.", The use of multiple imaging technologies...

Breaking Medicine Technology:Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2 Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2 Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3 Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4 Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5 Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6 Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2 Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3 Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4 Are PET Scans Beneficial During Cancer Diagnosis, Staging and Monitoring? 2 Seeking sustainability in a world of instability 2198 1 Seeking sustainability in a world of instability 2198 2 Duragesic Trials Continue Plaintiffs Optimistic After Latest Recall 11870 1 Duragesic Trials Continue Plaintiffs Optimistic After Latest Recall 11870 2 Cancer Drug Works Against MS in Early Trial 11869 1 Cancer Drug Works Against MS in Early Trial 11869 2 Cancer Drug Works Against MS in Early Trial 11869 3 Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results 3275 1

[1] Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment [0] Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab [0] Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders [0] Are PET Scans Beneficial During Cancer Diagnosis, Staging and Monitoring?

...wire-FirstCall/ -- Vical,Incorporated today announ...ith the company,s Vaxfectin(TM) adjuvant generated...nformulated vaccine,at the same dose in a recently...steur,s Fluzone(R) commercial vaccine with,Vaxfect...vaccine,dose while generating equivalent or better...

...Apr 10, 2007 - Valeant,Pharmaceuticals Internation...hase 2 data for retigabine, a first-in-class,neuro...ing,independent, scientific journal. The authors c...monstrated reduction in monthly,seizure rates in t...d RESTORE2) are currently underway to further inve...

Other Medicine Technology:Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine 2 Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine 3 Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine 4 Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine 5 Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology 2 Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology 3

Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology